Investor ATAI Life Sciences B.V.
13D/G Filings

This page shows a list of all the recent 13D/G filings made by ATAI Life Sciences B.V. . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2025-03-05 13D/A CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock) 6,905,774 6,905,774
2024-09-27 13D/A CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock) 9,435,758 6,905,774
2024-05-03 13D/A IGXT / IntelGenx Technologies Corp. 257,627,407 263,032,812
2024-03-12 13D/A IGXT / IntelGenx Technologies Corp. 257,679,100 257,627,407
2023-09-07 13D/A IGXT / IntelGenx Technologies Corp. 233,680,000 257,679,100
2021-12-01 13D/A CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock) 8,694,758 9,435,758
2021-11-29 13D/A CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock) 8,075,663 8,694,758
2021-05-24 13D CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock) 8,075,663
2021-05-24 13D IGXT / IntelGenx Technologies Corp. 233,680,000